COMPETITIVE ACQUISITION: CMS Pulls The Plug On Drug Bidding Program

Article Overview

This article covers CMS’s decision to suspend the bidding process for the Competitive Acquisition Program for Part B drugs, along with the broader reactions from physicians, oncology practices, and prospective vendors. It is relevant to readers following Medicare drug payment policy, oncology reimbursement, vendor participation concerns, and implementation timing for the CAP demonstration. The discussion centers on why the program drew criticism and what CMS said about next steps, comment periods, and future delivery timing.